IL7R and acute lymphoblastic leukemia: IL7/IL7R-mediated binding activates three main signaling pathways: Jak/STAT, MAPK/Erk and PI3K/Akt/mammalian target of rapamycin (mTOR) [32] in both T-ALL and healthy T-cells [33,34].